The recent decision by the U.S. Food and Drug Administration (FDA) to ban the use of Red Dye No. 3 (also known as FD&C Red No. 3 or erythrosine) marks a significant step in addressing long-standing concerns about the safety of synthetic food dyes. This dye, commonly used to impart a bright cherry-red color to various foods and ingested drugs, has been linked to health risks, particularly cancer, in laboratory studies. The ban highlights a shift towards prioritizing consumer safety over the convenience and aesthetic appeal of artificial coloring in food products.

Why Now?
Red Dye No. 3 has been under scrutiny for decades due to evidence suggesting its potential to cause cancer. Research involving laboratory animals demonstrated that prolonged exposure to erythrosine increased the risk of thyroid tumors. These findings prompted health advocates and scientists to raise concerns about its continued use, especially in products marketed toward children, who are particularly vulnerable to chemical exposures due to their smaller body sizes and developing systems.

In response to these concerns, the FDA recently announced its decision to ban the use of Red Dye No. 3 in food products and ingested medications. The agency’s move aligns with the Delaney Clause of the Federal Food, Drug, and Cosmetic Act, which prohibits the use of any additive found to cause cancer in humans or animals. Although the FDA had already banned the dye in cosmetics and topical applications in 1990, its use in foods and oral medications remained legal until now. The recent action corrects this inconsistency and reflects a broader commitment to safeguarding public health.

A Closer Look
Red Dye No. 3 is a synthetic dye derived from petroleum. It has been widely used for its vibrant red hue, which enhances the visual appeal of various foods and beverages. Products such as candies, cakes, cookies, frostings, and frozen desserts frequently contain this dye. Additionally, it is found in certain medications, where it is used to color pills and syrups, and in dietary supplements.

Despite its widespread use, Red Dye No. 3 has faced growing opposition from consumer advocacy groups and health experts. Studies have linked artificial food dyes, including erythrosine, to a range of health issues beyond cancer, such as hyperactivity in children and allergic reactions. These concerns have fueled calls for stricter regulations and prompted some manufacturers to voluntarily eliminate synthetic dyes from their products in favor of natural alternatives.
Foods and Products Affected by the Ban
The ban on Red Dye No. 3 will have a significant impact on the food and pharmaceutical industries. Affected products include:
Candies: Brightly colored sweets like gummies, lollipops, and hard candies often rely on Red Dye No. 3 for their signature hues.

Baked Goods: Frostings, glazes, and certain types of cakes and cookies frequently contain the dye to achieve a festive appearance.
Frozen Desserts: Ice creams, popsicles, and sorbets that feature red tones may need reformulation.
Medications: Over-the-counter and prescription medications, including liquid syrups and coated pills, may need alternative coloring agents.
Dietary Supplements: Capsules and chewable vitamins often use synthetic dyes for visual appeal and brand differentiation.
Manufacturers of these products will have until January 2027 to reformulate their recipes and comply with the new regulations for food items. For ingested medications, the deadline extends to January 2028, providing additional time for pharmaceutical companies to adjust.
Consumer Response and Industry Adaptation
The FDA’s decision has been met with a mixed response. Public health advocates and consumer organizations have welcomed the ban as a long-overdue measure to protect consumers from harmful substances. They argue that the risks associated with synthetic dyes outweigh their aesthetic benefits and point to the availability of safer, natural alternatives derived from fruits, vegetables, and spices.
On the other hand, some industry stakeholders have expressed concerns about the challenges of reformulating products. Synthetic dyes like Red Dye No. 3 are inexpensive, stable, and offer vibrant colors that are difficult to replicate using natural alternatives. Transitioning to natural dyes may increase production costs and pose technical challenges, such as shorter shelf lives and variations in color intensity.
Despite these challenges, many companies have already begun phasing out synthetic dyes in response to changing consumer preferences. The clean-label movement, which emphasizes transparency and natural ingredients, has gained significant traction in recent years. Major brands have reformulated their products to eliminate artificial colors and flavors, signaling a broader industry shift toward cleaner and more sustainable practices.
Global Perspective on Synthetic Dyes
The FDA’s ban on Red Dye No. 3 brings the United States closer to international standards. In the European Union, erythrosine has been banned for use in food since 1990, except for specific applications such as coloring certain types of cherries. Australia and New Zealand have also prohibited its use in foods. These bans reflect a global recognition of the potential risks posed by synthetic dyes and underscore the importance of harmonizing food safety regulations worldwide.
In countries where synthetic dyes remain legal, advocacy groups continue to push for stricter oversight and labeling requirements. Educating consumers about the potential risks of artificial additives is a key component of these efforts. As awareness grows, more consumers are likely to demand products free from synthetic dyes, prompting further industry changes.
Looking Ahead
The FDA’s decision to ban Red Dye No. 3 represents a significant milestone in the ongoing effort to improve food safety and public health. While the transition away from synthetic dyes may pose challenges for manufacturers, it also presents opportunities for innovation and growth. Companies that embrace natural and clean-label solutions are likely to gain a competitive edge in a market increasingly driven by health-conscious consumers.
For consumers, the ban underscores the importance of staying informed about the ingredients in their food and medications. By reading labels and choosing products made with natural alternatives, individuals can reduce their exposure to potentially harmful substances and support a safer, more sustainable food system.
As the January 2027 and 2028 deadlines approach, the FDA will likely continue to work closely with manufacturers to ensure a smooth transition. The agency’s action serves as a reminder of the critical role regulatory bodies play in protecting public health and promoting scientific advancements that benefit society as a whole.
The ban on Red Dye No. 3 is a pivotal step toward reducing the risks associated with synthetic food dyes and ensuring the safety of the food supply. By prioritizing public health over cosmetic appeal, the FDA has sent a clear message about the importance of science-based decision-making in food regulation. While challenges remain, the shift away from artificial dyes offers an opportunity to embrace safer, more natural alternatives that align with consumer values and contribute to a healthier future for all.